Literature DB >> 21132238

[Hemolytic anemia due to hemoglobin Evans in an Argentinean family].

María I Zanotto1, Karina Calvo, Gabriel Schvartzman, Alejandra Deana, Nélida Noguera, Irma Bragós, Angela Milani.   

Abstract

Unstable hemoglobins are structural variants of the hemoglobin molecule, mostly originated by single amino-acid replacement in some globin chains. These changes affect molecule stability, leading to loss of solubility, precipitation, and cellular lysis. Patients carrying these unstable hemoglobins may present mild to severe chronic hemolytic anemia. Hemoglobin Evans is an unstable variant originated by replacement of valine with methionine at position 62 of the α-globin chain. We have identified this variant in a girl with an acute hemolytic crisis associated to pharyngitis, as well as in two of her family members. This is the third case of hemolytic anemia due to hemoglobin Evans reported in the literature.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21132238     DOI: 10.1590/S0325-00752010000600015

Source DB:  PubMed          Journal:  Arch Argent Pediatr        ISSN: 0325-0075            Impact factor:   0.635


  3 in total

1.  Post-translational transformation of methionine to aspartate is catalyzed by heme iron and driven by peroxide: a novel subunit-specific mechanism in hemoglobin.

Authors:  Michael Brad Strader; Wayne A Hicks; Tigist Kassa; Eileen Singleton; Jayashree Soman; John S Olson; Mitchell J Weiss; Todd L Mollan; Michael T Wilson; Abdu I Alayash
Journal:  J Biol Chem       Date:  2014-06-17       Impact factor: 5.157

2.  A First Report of Hb Alesha [β67(E11)Val>Met, GTG>ATG] in an Iranian Patient

Authors:  Mohammad Hamid; Ebtesam Zargan Nezhad; Hamid Galehdari; Alihossein Saberi; Gholamreza Shariati; Alireza Sedaghat
Journal:  Iran Biomed J       Date:  2018-10-14

3.  Choledocholithiases in a child with Hemoglobin Evans [alpha2 62(E11) Val→Met].

Authors:  Itaru Hayakawa; Hiroshi Hataya; Takashi Kaneko
Journal:  Clin Case Rep       Date:  2016-06-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.